Méndez, M <br/><br/>
Weekly irinotecan plus UFT and leucovorin as first-line chemotherapy of patients with advanced colorectal cancer.  [electronic resource] 

 -  Investigational new drugs  Jun 2005 
 - 243-51 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0167-6997 
<br/><br/><label>Standard No.: </label>10.1007/s10637-005-6733-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Camptothecin--administration & dosage<br/>Colorectal Neoplasms--drug therapy<br/>Female<br/>Humans<br/>Irinotecan<br/>Leucovorin--administration & dosage<br/>Male<br/>Middle Aged<br/>Tegafur--administration & dosage<br/>Uracil--administration & dosage